BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-631@pharmaconomics
DTSTAMP:20260707T040401Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:TVRD Phase 1 — TTI-109
DESCRIPTION:Phase 1 trial results for TTI-109 in its lead indication are due Jun 30\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1346830/000110465926057524/tm2613977d1_ex99-1.htm\n\nTrack it: https://www.pharmaconomics.com/e/631
URL:https://www.pharmaconomics.com/e/631
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:TVRD catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR